The association of immunoglobulin A, immunoglobulin G and anti-cyclic citrullinated peptide antibodies with disease activity in seronegative rheumatoid arthritis patients
- PMID: 25535495
- PMCID: PMC4268189
The association of immunoglobulin A, immunoglobulin G and anti-cyclic citrullinated peptide antibodies with disease activity in seronegative rheumatoid arthritis patients
Abstract
Background: Rheumatoid arthritis (RA) is a common autoimmune disease that is associated with progressive disability, systemic complications, and early death. The present study was aimed to investigate the level of immunoglobulin G (IgG) and IgA isotypes and anti-cyclic citrullinated peptide (CCP) antibody and to assess their association with disease severity based on disease activity score (DAS-28) in patients with IgM rheumatoid factor (IgM-RF) negative RA.
Materials and methods: In this cross-sectional study, 62 RA patients with IgM-RF negative were assessed. Radiographs were obtained for all RA patients. The RF (IgG, and IgA) and anti-CCP were measured by using the enzyme-linked immunosorbent assay. Values of cut-off points over 15 UI/mL for IgA IgA-RF, 20 UI/mL for IgG-RF and over 20 units for anti-CCP were considered positive. DAS-28 score was compared in regard to the IgA-RF and IgG-RF and anti-CCP positivity using Mann-Whitney test.
Results: DAS-28 score in IgA-RF positive was significantly higher than IgA-RF negative (mean score, 6.03 ± 0.33 vs. 5.44 ± 0.76 respectively, P = 0.035). In IgG-RF positive patients, DAS-28 score was similar to patients with IgG-RF negative (5.64 ± 0.59 vs. 5.46 ± 0.78 respectively, P = 0.396). Furthermore, in patients with anti-CCP positive DAS-28 score was significantly higher than patients with anti-CCP negative (5.72 ± 0.61 vs. 5.38 ± 0.79 respectively, P = 0.049).
Conclusion: Findings indicated that there was a significant association between the amounts of IgA and anti-CCP with severity of disease in RF negative RA patients while there was no significant association between the amounts of IgG and severity of RA disease.
Keywords: Disease activity score-28; immunoglobulin A; immunoglobulin G; rheumatoid factor; seronegative rheumatoid arthritis.
Conflict of interest statement
Similar articles
-
Association of anti-cyclic citrullinated peptide antibodies, anti-citrullin antibodies, and IgM and IgA rheumatoid factors with serological parameters of disease activity in rheumatoid arthritis.Ann N Y Acad Sci. 2005 Jun;1050:295-303. doi: 10.1196/annals.1313.031. Ann N Y Acad Sci. 2005. PMID: 16014545
-
Autoantibodies in rheumatoid arthritis: association with severity of disease in established RA.Clin Rheumatol. 2007 Feb;26(2):201-4. doi: 10.1007/s10067-006-0275-5. Epub 2006 Mar 30. Clin Rheumatol. 2007. PMID: 16572283
-
Antibodies to Cyclic Citrullinated Peptides in Patients With Juvenile Idiopathic Arthritis and Patients With Rheumatoid Arthritis: Shared Expression of the Inherently Autoreactive 9G4 Idiotype.Arthritis Rheumatol. 2017 Jul;69(7):1387-1395. doi: 10.1002/art.40117. Epub 2017 Jun 5. Arthritis Rheumatol. 2017. PMID: 28380667
-
Meta-analysis: diagnostic accuracy of anti-cyclic citrullinated peptide antibody and rheumatoid factor for rheumatoid arthritis.Ann Intern Med. 2007 Jun 5;146(11):797-808. doi: 10.7326/0003-4819-146-11-200706050-00008. Ann Intern Med. 2007. PMID: 17548411 Review.
-
Rheumatoid Factor: Diagnostic and Prognostic Performance and Therapeutic Implications in Rheumatoid Arthritis.J Clin Med. 2025 Feb 25;14(5):1529. doi: 10.3390/jcm14051529. J Clin Med. 2025. PMID: 40094988 Free PMC article. Review.
Cited by
-
Immune Thrombosis: Exploring the Significance of Immune Complexes and NETosis.Biology (Basel). 2023 Oct 12;12(10):1332. doi: 10.3390/biology12101332. Biology (Basel). 2023. PMID: 37887042 Free PMC article. Review.
-
The effects of conventional drugs in the treatment of rheumatoid arthritis on the serum lipids.J Res Med Sci. 2018 Dec 28;23:105. doi: 10.4103/jrms.JRMS_869_17. eCollection 2018. J Res Med Sci. 2018. PMID: 30693040 Free PMC article.
-
IgA and FcαRI: Versatile Players in Homeostasis, Infection, and Autoimmunity.Immunotargets Ther. 2021 Jan 5;9:351-372. doi: 10.2147/ITT.S266242. eCollection 2020. Immunotargets Ther. 2021. PMID: 33447585 Free PMC article. Review.
-
Antagonizing FcαR1 (CD89) as treatment in IgA-mediated chronic inflammation and autoimmunity.Front Immunol. 2023 Apr 4;14:1118539. doi: 10.3389/fimmu.2023.1118539. eCollection 2023. Front Immunol. 2023. PMID: 37081893 Free PMC article.
-
IgA Immune Complexes Induce Osteoclast-Mediated Bone Resorption.Front Immunol. 2021 Jul 1;12:651049. doi: 10.3389/fimmu.2021.651049. eCollection 2021. Front Immunol. 2021. PMID: 34276648 Free PMC article.
References
-
- Majithia V, Geraci SA. Rheumatoid arthritis: Diagnosis and management. Am J Med. 2007;120:936–9. - PubMed
-
- Khurana R, Berney SM. Clinical aspects of rheumatoid arthritis. Pathophysiology. 2005;12:153–65. - PubMed
-
- Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988;31:315–24. - PubMed
-
- McInnes IB, Schett G. The pathogenesis of rheumatoid arthritis. N Engl J Med. 2011;365:2205–19. - PubMed
LinkOut - more resources
Full Text Sources
Miscellaneous